Combination of aspirin and clopidogrel for the prevention of thrombosis

Implications for the dental practitioner

Paulomi R. Shah, Juan Yepes, John A. Valenza

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The use of aspirin and Clopidogrel as effective antiplatelet therapy in preventing secondary thromboembolic events is well-established. However, there is controversy among dentists and physicians regarding the appropriate dental management of patients receiving dual antiplatelet therapy due to the lack of clinical studies about hemorrhagic risk in these patients. Indications for modifying dual antiplatelet therapy-whether it is done by altering doses, switching to monotherapy, or discontinuing It completely-occur infrequently, as most patients can be treated in a dental office setting. In all cases, patients must be managed jointly by the dentist and physician, taking into account the patient's medical and dental history. This article reviews the current use of aspirin and clopidogrel as combination therapy, examining their effect on platelet function, the associated hemorrhagic risk during dental procedures for patients using this therapy, and how oral health care providers can manage these patients safely and effectively.

Original languageEnglish (US)
Pages (from-to)517-522
Number of pages6
JournalGeneral Dentistry
Volume55
Issue number6
StatePublished - Nov 1 2007
Externally publishedYes

Fingerprint

clopidogrel
Aspirin
Tooth
Thrombosis
Dentists
Dental Offices
Physicians
Therapeutics
Oral Health
Health Personnel

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Combination of aspirin and clopidogrel for the prevention of thrombosis : Implications for the dental practitioner. / Shah, Paulomi R.; Yepes, Juan; Valenza, John A.

In: General Dentistry, Vol. 55, No. 6, 01.11.2007, p. 517-522.

Research output: Contribution to journalArticle

@article{e93b9069aa7b4fa99571a1ea64fc43dd,
title = "Combination of aspirin and clopidogrel for the prevention of thrombosis: Implications for the dental practitioner",
abstract = "The use of aspirin and Clopidogrel as effective antiplatelet therapy in preventing secondary thromboembolic events is well-established. However, there is controversy among dentists and physicians regarding the appropriate dental management of patients receiving dual antiplatelet therapy due to the lack of clinical studies about hemorrhagic risk in these patients. Indications for modifying dual antiplatelet therapy-whether it is done by altering doses, switching to monotherapy, or discontinuing It completely-occur infrequently, as most patients can be treated in a dental office setting. In all cases, patients must be managed jointly by the dentist and physician, taking into account the patient's medical and dental history. This article reviews the current use of aspirin and clopidogrel as combination therapy, examining their effect on platelet function, the associated hemorrhagic risk during dental procedures for patients using this therapy, and how oral health care providers can manage these patients safely and effectively.",
author = "Shah, {Paulomi R.} and Juan Yepes and Valenza, {John A.}",
year = "2007",
month = "11",
day = "1",
language = "English (US)",
volume = "55",
pages = "517--522",
journal = "General Dentistry",
issn = "0363-6771",
publisher = "Academy of General Dentistry",
number = "6",

}

TY - JOUR

T1 - Combination of aspirin and clopidogrel for the prevention of thrombosis

T2 - Implications for the dental practitioner

AU - Shah, Paulomi R.

AU - Yepes, Juan

AU - Valenza, John A.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - The use of aspirin and Clopidogrel as effective antiplatelet therapy in preventing secondary thromboembolic events is well-established. However, there is controversy among dentists and physicians regarding the appropriate dental management of patients receiving dual antiplatelet therapy due to the lack of clinical studies about hemorrhagic risk in these patients. Indications for modifying dual antiplatelet therapy-whether it is done by altering doses, switching to monotherapy, or discontinuing It completely-occur infrequently, as most patients can be treated in a dental office setting. In all cases, patients must be managed jointly by the dentist and physician, taking into account the patient's medical and dental history. This article reviews the current use of aspirin and clopidogrel as combination therapy, examining their effect on platelet function, the associated hemorrhagic risk during dental procedures for patients using this therapy, and how oral health care providers can manage these patients safely and effectively.

AB - The use of aspirin and Clopidogrel as effective antiplatelet therapy in preventing secondary thromboembolic events is well-established. However, there is controversy among dentists and physicians regarding the appropriate dental management of patients receiving dual antiplatelet therapy due to the lack of clinical studies about hemorrhagic risk in these patients. Indications for modifying dual antiplatelet therapy-whether it is done by altering doses, switching to monotherapy, or discontinuing It completely-occur infrequently, as most patients can be treated in a dental office setting. In all cases, patients must be managed jointly by the dentist and physician, taking into account the patient's medical and dental history. This article reviews the current use of aspirin and clopidogrel as combination therapy, examining their effect on platelet function, the associated hemorrhagic risk during dental procedures for patients using this therapy, and how oral health care providers can manage these patients safely and effectively.

UR - http://www.scopus.com/inward/record.url?scp=36048956052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048956052&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 517

EP - 522

JO - General Dentistry

JF - General Dentistry

SN - 0363-6771

IS - 6

ER -